Hardman Johnston Global Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Hardman Johnston Global Advisors LLC

  • $1.98 Billion
  • Q3 2025

A detailed history of Hardman Johnston Global Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hardman Johnston Global Advisors LLC holds 79,152 shares of VRTX stock, worth $34.4 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares
79,152
Previous 108,225 26.86%
Holding current value
$34.4 Million
Previous $48.2 Million 35.66%
% of portfolio
1.57%
Previous 2.28%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 27, 2025
SELL
$366.54 - $479.53 $10.7 Million - $13.9 Million
-29,073 Reduced 26.86%
79,152 $31 Million
Q2 2025

Jul 21, 2025
SELL
$421.16 - $509.5 $4.15 Million - $5.02 Million
-9,855 Reduced 8.35%
108,225 $48.2 Million
Q1 2025

May 15, 2025
BUY
$402.49 - $513.76 $1.37 Million - $1.76 Million
3,416 Added 2.98%
118,080 $57.2 Million
Q4 2024

Feb 04, 2025
SELL
$396.64 - $516.74 $97,176 - $126,601
-245 Reduced 0.21%
114,664 $46.2 Million
Q3 2024

Oct 30, 2024
SELL
$460.0 - $505.78 $3.18 Million - $3.5 Million
-6,911 Reduced 5.67%
114,909 $53.4 Million
Q2 2024

Aug 14, 2024
SELL
$392.81 - $485.53 $14.5 Million - $17.9 Million
-36,961 Reduced 23.28%
121,820 $57.1 Million
Q1 2024

May 06, 2024
SELL
$407.69 - $446.08 $5.78 Million - $6.33 Million
-14,180 Reduced 8.2%
158,781 $66.4 Million
Q4 2023

Jan 29, 2024
SELL
$343.0 - $410.68 $988,526 - $1.18 Million
-2,882 Reduced 1.64%
172,961 $70.4 Million
Q3 2023

Oct 20, 2023
SELL
$338.18 - $362.46 $546,837 - $586,097
-1,617 Reduced 0.91%
175,843 $61.1 Million
Q2 2023

Aug 11, 2023
SELL
$314.42 - $351.91 $3.1 Million - $3.47 Million
-9,864 Reduced 5.27%
177,460 $62.4 Million
Q1 2023

May 05, 2023
SELL
$283.23 - $323.1 $5.5 Million - $6.27 Million
-19,403 Reduced 9.39%
187,324 $59 Million
Q4 2022

Feb 03, 2023
SELL
$285.76 - $321.48 $2.08 Million - $2.34 Million
-7,273 Reduced 3.4%
206,727 $59.7 Million
Q3 2022

Nov 02, 2022
SELL
$273.83 - $305.53 $4.91 Million - $5.47 Million
-17,914 Reduced 7.72%
214,000 $62 Million
Q2 2022

Aug 02, 2022
SELL
$234.96 - $292.55 $3.08 Million - $3.83 Million
-13,090 Reduced 5.34%
231,914 $65.4 Million
Q1 2022

May 12, 2022
BUY
$221.42 - $260.97 $8.06 Million - $9.49 Million
36,380 Added 17.44%
245,004 $63.9 Million
Q4 2021

Jan 26, 2022
BUY
$177.01 - $223.45 $3.53 Million - $4.46 Million
19,950 Added 10.57%
208,624 $45.8 Million
Q3 2021

Nov 12, 2021
SELL
$181.39 - $202.99 $635,771 - $711,479
-3,505 Reduced 1.82%
188,674 $34.2 Million
Q2 2021

Aug 09, 2021
SELL
$187.49 - $221.1 $752,772 - $887,716
-4,015 Reduced 2.05%
192,179 $38.7 Million
Q1 2021

May 12, 2021
BUY
$207.02 - $241.31 $103,510 - $120,655
500 Added 0.26%
196,194 $42.2 Million
Q4 2020

Feb 11, 2021
SELL
$207.01 - $276.09 $203,904 - $271,948
-985 Reduced 0.5%
195,694 $46.3 Million
Q3 2020

Nov 16, 2020
SELL
$255.65 - $303.1 $642,959 - $762,296
-2,515 Reduced 1.26%
196,679 $53.5 Million
Q2 2020

Jul 23, 2020
SELL
$225.48 - $295.8 $4.28 Million - $5.61 Million
-18,960 Reduced 8.69%
199,194 $57.8 Million
Q1 2020

May 04, 2020
SELL
$199.77 - $247.81 $209,758 - $260,200
-1,050 Reduced 0.48%
218,154 $51.9 Million
Q4 2019

Feb 05, 2020
SELL
$166.71 - $223.91 $1.34 Million - $1.8 Million
-8,056 Reduced 3.54%
219,204 $48 Million
Q3 2019

Oct 30, 2019
SELL
$166.23 - $187.09 $297,551 - $334,891
-1,790 Reduced 0.78%
227,260 $38.5 Million
Q2 2019

Aug 05, 2019
SELL
$164.61 - $190.37 $1.57 Million - $1.81 Million
-9,520 Reduced 3.99%
229,050 $42 Million
Q1 2019

May 03, 2019
SELL
$163.73 - $194.7 $657,375 - $781,720
-4,015 Reduced 1.66%
238,570 $43.9 Million
Q4 2018

Feb 06, 2019
SELL
$151.91 - $192.21 $1.46 Million - $1.85 Million
-9,635 Reduced 3.82%
242,585 $40.2 Million
Q3 2018

Oct 18, 2018
SELL
$167.73 - $192.74 $659,178 - $757,468
-3,930 Reduced 1.53%
252,220 $48.6 Million
Q2 2018

Jul 18, 2018
BUY
$145.72 - $169.96 $9.8 Million - $11.4 Million
67,250 Added 35.6%
256,150 $43.5 Million
Q1 2018

Apr 30, 2018
BUY
$151.6 - $177.13 $28.6 Million - $33.5 Million
188,900 New
188,900 $30.8 Million

Others Institutions Holding VRTX

# of Institutions
1,786
Shares Held
231M
Call Options Held
1.83M
Put Options Held
1.21M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $111B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Hardman Johnston Global Advisors LLC Portfolio

Follow Hardman Johnston Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hardman Johnston Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hardman Johnston Global Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email